Literature DB >> 28474700

Triglyceride/high-density lipoprotein cholesterol (TG/HDL-C) index as a reference criterion of risk for metabolic syndrome (MetS) and low insulin sensitivity in apparently healthy subjects.

Blanca Guadalupe Baez-Duarte1, Irma Zamora-Gínez1, Ramiro González-Duarte2, Enrique Torres-Rasgado1, Guadalupe Ruiz-Vivanco1, Ricardo Pérez-Fuentes1,3, The Multidisciplinary Research Group Of Diabetes Celis.   

Abstract

AIM: To evaluate if the TG/HDL-C index can be considered as a reference criterion of MetS and low insulin sensitivity in apparently healthy subjects.
METHODS: The subjects were Mexican mestizos who resided in Puebla City, Mexico, who were anthropometrically, biochemically, and clinically characterized. The TG/HDL-C index was calculated by dividing triglyceride (TG) levels by HDL-C levels. MetS was diagnosed by the Third Report from the Adult Treatment Panel-National Cholesterol Education Program (ATP-III NCEP) criteria, while insulin sensitivity was evaluated by the Quantitative Insulin sensitivity Check Index (QUICKI).
RESULTS: The study included 813 subjects, with an average age of 38.6 ± 12.1 years, of which 564 were women and 249 men. An association was found between high TG/HDL-C index and low insulin sensitivity (Odds ratio [OR]: 4.09; p < 0.01) and with MetS (OR: 15.29; p < 0.01). A correlation was found between the TG/HDL-C index and QUICKI (rho: -0.4989; p < 0.01) and with MetS (rho: 0.6581; p < 0.01).
CONCLUSION: The results indicate that the TG/HDL-C index is associated with low insulin sensitivity and MetS in apparently healthy subjects, suggesting this index as a reference criterion of risk for low insulin sensitivity and MetS.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28474700

Source DB:  PubMed          Journal:  Gac Med Mex        ISSN: 0016-3813            Impact factor:   0.302


  6 in total

1.  Triglyceride to high-density lipoprotein cholesterol (HDL-C) ratio and arterial stiffness in Japanese population: a secondary analysis based on a cross-sectional study.

Authors:  Chi Chen; Jia-Lin Dai
Journal:  Lipids Health Dis       Date:  2018-05-29       Impact factor: 3.876

2.  Use of Blood Lipid Indicators as a Screening Tool of Insulin Resistance among Individuals in Low-Income Country Sides of China: A Multiethnic Region Study.

Authors:  Yi-Zhong Yan; Jia-Ning Fan; Jia-Ming Liu; Yun-Hua Hu; Jiao-Long Ma; Jia He; Heng Guo; Xiang-Hui Zhang; Xin-Ping Wang; Shu-Gang Li; Shu-Xia Guo
Journal:  Mediators Inflamm       Date:  2019-10-07       Impact factor: 4.711

3.  Control of Obesity, Blood Glucose, and Blood Lipid with Olax imbricata Roxb. Root Extract in High-Fat Diet-Induced Obese Mice.

Authors:  Thi Nga Vo; Thi-Diem-My Luong; Thi-Phuong-Hoa Le; Khanh Son Trinh
Journal:  J Toxicol       Date:  2022-09-02

4.  Postprandial Glycemic and Insulinemic Response by a Brewer's Spent Grain Extract-Based Food Supplement in Subjects with Slightly Impaired Glucose Tolerance: A Monocentric, Randomized, Cross-Over, Double-Blind, Placebo-Controlled Clinical Trial.

Authors:  Hammad Ullah; Cristina Esposito; Roberto Piccinocchi; Lorenza Francesca De Lellis; Cristina Santarcangelo; Alessandro Di Minno; Alessandra Baldi; Daniele Giuseppe Buccato; Ayesha Khan; Gaetano Piccinocchi; Roberto Sacchi; Maria Daglia
Journal:  Nutrients       Date:  2022-09-21       Impact factor: 6.706

5.  High triglyceride to HDL-cholesterol ratio as a biochemical marker of severe outcomes in COVID-19 patients.

Authors:  Estefanía Alcántara-Alonso; Fernando Molinar-Ramos; Jesús Alberto González-López; Viridiana Alcántara-Alonso; Marco Antonio Muñoz-Pérez; José Juan Lozano-Nuevo; Daniel Rabindranath Benítez-Maldonado; Elizabeth Mendoza-Portillo
Journal:  Clin Nutr ESPEN       Date:  2021-05-07

6.  Triglyceride to HDL-cholesterol ratio as an independent risk factor for the poor development of coronary collateral circulation in elderly patients with ST-segment elevation myocardial infarction and acute total occlusion.

Authors:  Guo-Yong Liu; Xiao-Xue Meng; Zheng Zhang
Journal:  Medicine (Baltimore)       Date:  2018-09       Impact factor: 1.889

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.